---
{"dg-publish":true,"uplink":"/statistics/statistics/","uptext":"Back to Index (🔢 Statistics)","permalink":"/statistics/randomized-controlled-trials-rct/","dgPassFrontmatter":true}
---

## Definition And Overview

A randomized controlled trial (RCT) is an interventional study design. Subjects are randomly allocated to different treatment options. RCTs are considered the gold standard of individual medical research studies. They generate reliable safety and efficacy data for health interventions such as drugs, diagnostics, and therapy protocols.

- The primary goal is to assess the effect of an intervention against an active agent, an inert substance (placebo), or usual care.
- They limit the potential for bias by randomly assigning patient pools to different groups.
- Random allocation ensures that both known and unknown confounding factors are distributed equally.

## Phases Of Clinical Trials

Clinical trials evaluating new drugs are generally categorized into four sequential phases.

- **Phase I**: Small studies conducted on healthy volunteers or patients. These studies determine the toxicity and maximum tolerated dose of a new treatment.
- **Phase II**: Initial clinical investigations aimed at evaluating treatment effect and short-term safety.
- **Phase III**: Full-scale evaluation trials. They compare the new treatment with a standard treatment or a placebo.
- **Phase IV**: Studies conducted after a drug is marketed. These post-licensure studies provide additional details about long-term safety, efficacy, and usage profiles.

## Key Statistical Principles

Executing a valid RCT requires adherence to specific statistical principles during the design stage.

### Randomization

- Randomization minimizes the chance that confounding variables differ between the study groups.
- It enhances the consistency of distributions of uncontrolled factors among the compared groups.
- **Simple Randomization**: Each patient has a defined probability, usually 50/50, of receiving the new drug or the placebo.
- **Block Randomization**: Divides patients into homogeneous blocks to ensure treatment balance during recruitment.
- **Stratified Randomization**: Groups patients according to pre-specified covariate values (like gender or age) to form strata before randomizing.

### Control Groups

- A proper control group must be established to manifest the true effect of the treatment.
- **Placebo-Controlled**: The control group receives an inert material or a sham surgery.
- **Active-Controlled**: The control group receives a standard active drug.

### Blinding And Allocation Concealment

- **Allocation Concealment**: Hides the randomization schedule from caregivers. It prevents investigators from preferentially recruiting unhealthier participants to a specific arm.
- **Blinding (Masking)**: Withholds information about treatment allocation from patients, physicians, or statisticians. Blinding eliminates bias due to subjectivity in reporting or evaluating data.
- **Open-Label**: No blinding is used. Both the patient and physicians know the treatment allocations.
- **Single-Blinded**: The patient does not know which drug they are taking.
- **Double-Blinded**: Both the patient and the investigator are unaware of the treatment allocation.
- **Triple-Blinded**: The patient, investigator, and the biostatistician analyzing the data are kept unaware of the allocations.

## Common RCT Designs

RCTs can utilize different structural designs based on the nature of the disease and the intervention.

|Study Design|Description|Key Features|
|:--|:--|:--|
|**Parallel Design**|Patients are randomized to one of the treatment groups.|The most common design. Each patient receives only one type of treatment.|
|**Cross-Over Design**|Each participant is exposed to both the control and intervention in a sequence.|Each individual serves as his or her own control. Requires a washout period to eliminate carry-over effects.|
|**Factorial Design**|Tests the effect of more than one treatment simultaneously.|Smaller sample size is needed than individual trials. It allows the assessment of potential interactions among treatments.|
|**Cluster Randomized Trials**|Groups or clusters of individuals are randomly allocated rather than individuals.|Unit of randomization can be families, hospitals, or schools. Used to avoid treatment contamination.|

## Trial Objectives

RCTs can also be categorized based on their underlying hypothesis testing goals.

|Trial Type|Objective|Interpretation|
|:--|:--|:--|
|**Superiority Trial**|Aims to prove that the new drug is better than a placebo or current treatment.|Must have power to detect a clinically meaningful difference.|
|**Non-Inferiority Trial**|Aims to prove that the new drug is no worse than the current treatment.|The treatment must not be worse than the control by a pre-specified non-inferiority margin.|
|**Equivalence Trial**|Aims to determine whether one intervention is therapeutically similar to another.|Tests whether the treatment effect lies within a pre-defined equivalence margin.|

## Statistical Analysis Of RCTs

Choosing the correct population for statistical analysis is crucial for minimizing bias at the reporting stage.

### Intention-To-Treat (ITT) Analysis

- ITT analyzes all patients based on their original allocated group.
- This applies regardless of the actual treatment received, crossovers, or dropouts.
- It is considered the gold standard for clinical trials.
- ITT preserves the benefits of randomization and avoids attritional bias.
- It provides a pragmatic estimate of the population-level effect.

### Per-Protocol Analysis

- Analyzes only the patients who strictly complied with the trial protocol.
- Excludes patients who dropped out or crossed over to the other group.
- It evaluates the effect of adherence to treatment assignment.
- It is highly susceptible to confounding bias because the analyzed groups may no longer be adequately randomized.

### As-Treated Analysis

- Patients are analyzed according to the actual treatment they received.
- Ignores the original randomization allocation.
- It gives the maximum estimate of treatment effects but is extremely vulnerable to selection bias.

## Advantages And Disadvantages

|Advantages|Disadvantages|
|:--|:--|
|Provides stronger evidence compared to observational studies.|Trials can be very costly and require extensive resources.|
|Demonstrates causality effectively.|Long follow-up periods might be needed for certain clinical outcomes.|
|Randomization successfully controls for unmeasured confounding variables.|Non-compliance or loss to follow-up (attrition) severely affects validity.|
|Serves as the gold standard for generating scientific evidence for new interventions.|Concerns exist regarding external validity, as trial participants may not represent the general population.|
|Directly compares a new intervention against current standard care.|Sometimes impossible to conduct due to ethical or practical considerations.|